Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Liaoning He Eye Hospital Group Co., LTD. (301103.SZ)

21.44
+2.81
+(15.08%)
At close: April 25 at 3:04:49 PM GMT+8
Loading Chart for 301103.SZ
  • Previous Close 18.63
  • Open 18.49
  • Bid 21.44 x --
  • Ask 21.45 x --
  • Day's Range 19.82 - 22.05
  • 52 Week Range 16.24 - 28.96
  • Volume 8,754,367
  • Avg. Volume 1,636,203
  • Market Cap (intraday) 3.388B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.12
  • Earnings Date --
  • Forward Dividend & Yield 0.61 (2.82%)
  • Ex-Dividend Date Jul 5, 2024
  • 1y Target Est --

Liaoning He Eye Hospital Group Co., LTD. provides eye medical service and optometry services. It offers ophthalmopathy in children and elderly, refraction, and ocular surface services. The company was founded in 1995 and is based in Shenyang, China.

www.hsyk.com.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 301103.SZ

View More

Performance Overview: 301103.SZ

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

301103.SZ
6.56%
SSE Composite Index (000001.SS)
1.69%

1-Year Return

301103.SZ
12.84%
SSE Composite Index (000001.SS)
7.93%

3-Year Return

301103.SZ
14.71%
SSE Composite Index (000001.SS)
12.52%

5-Year Return

301103.SZ
45.35%
SSE Composite Index (000001.SS)
17.32%

Compare To: 301103.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 301103.SZ

View More

Valuation Measures

Annual
As of 4/24/2025
  • Market Cap

    2.94B

  • Enterprise Value

    1.73B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.65

  • Price/Book (mrq)

    1.52

  • Enterprise Value/Revenue

    1.57

  • Enterprise Value/EBITDA

    111.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.16%

  • Return on Assets (ttm)

    0.15%

  • Return on Equity (ttm)

    -1.60%

  • Revenue (ttm)

    1.1B

  • Net Income Avi to Common (ttm)

    -23.84M

  • Diluted EPS (ttm)

    -0.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.33B

  • Total Debt/Equity (mrq)

    11.20%

  • Levered Free Cash Flow (ttm)

    101.17M

Research Analysis: 301103.SZ

View More

Company Insights: 301103.SZ

Research Reports: 301103.SZ

View More

People Also Watch